在结肠癌转移的发展过程中,中性选择和克隆扩张
Xuelian Lei1, Daisuke Yamamoto2, Hirotaka Kitamura3
1Division of Genetics, Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan.
Journal of biochemistry
|June 18, 2024
概括
癌症转移包括克隆选择. 这项研究表明,在肝转移期间,随机中性选择,而不是细胞内在的特征,决定了哪些瘤亚克隆占主导地位,导致大瘤的多样性减少.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 遗传学 是一个遗传学.
背景情况:
- 瘤内部的异质性会影响癌症的进展.
- 初级瘤中的克隆进化已被理解,但其在转移性瘤发生中的作用尚不清楚.
研究的目的:
- 为了研究肝转移发育期间的克隆动态.
- 了解转移殖民中的子克隆选择的机制.
主要方法:
- 确定的人类结肠癌衍生器官.
- 利用带有条码标记的子克隆来追踪克隆动态.
- 同时移植的有机体亚克隆进入免疫缺陷小鼠脏.
- 在发育肝脏瘤时分析了克隆多样性.
主要成果:
- 长期的共同培养显示了克隆漂移,其中一个子克隆占主导地位.
- 肝脏瘤显示克隆多样性急剧减少,只有少数亚克隆占主导地位.
- 亚克隆选择似乎是随机的,不基于细胞内在特性.
- 在小鼠肠道瘤转移中观察到类似的克隆多样性减少趋势.
结论:
- 提出一种新的转移发育机制,涉及中性选择.
- 肝脏中传播的瘤细胞在殖民期间受到中性选择.
- 这种中性选择过程导致大转移性瘤的形成,并减少了克隆多样性.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Selectins
3.3K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.3K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


